| Name | (2S,4S)-4-fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}pyrrolidine-2-carbonitrile | 
|---|---|
| Synonyms | 
                                
                                (2S,4S)-2-cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine
                                
                                
                                 DPP-IV-IN-1  | 
                        
| Description | DPP-IV-IN-1 is a potent inhibitor of dipeptidyl peptidase IV (DPP-IV), a highly specific serine protease, with an IC50 of 4.6 nM. | 
|---|---|
| Related Catalog | |
| In Vivo | DPP-IV-IN-1 (0.1 and 0.3 mg/kg, p.o.) reduces the increase in plasma glucose beginning 30 min after glucose loading, and significantly suppresses hyperglycemia at the dose of 0.3 mg/kg in a rat model of obesity and impaired glucose tolerance. The effect is based on its inhibitory effect on plasma DPP-IV activity[1]. | 
| References | 
| Molecular Formula | C11H18FN3O2 | 
|---|---|
| Molecular Weight | 243.27800 | 
| Exact Mass | 243.13800 | 
| PSA | 76.36000 | 
| LogP | 0.13828 |